The prevalence and spectrum of alpha and beta thalassaemia in Guangdong Province: implications for the future health burden and population screening
- PMID: 15113860
- PMCID: PMC1770296
- DOI: 10.1136/jcp.2003.014456
The prevalence and spectrum of alpha and beta thalassaemia in Guangdong Province: implications for the future health burden and population screening
Abstract
Aim: Thalassaemia is a good candidate disease for control by preventive genetic programmes in developing countries. Accurate population frequency data are needed for planning the control of thalassaemia in the high risk Guangdong Province of southern China.
Methods: In total, 13397 consecutive samples from five geographical areas of Guangdong Province were analysed for both haematological and molecular parameters.
Results: There was a high prevalence of carriers of alpha thalassaemia (8.53%), beta thalassaemia (2.54%), and both alpha and beta thalassaemia (0.26%). Overall, 11.07% of the population in this area were heterozygous carriers of alpha and beta thalassaemia. The mutation spectrum of alpha and beta thalassaemia and its constitution were fully described in this area. This study reports the true prevalence of silent alpha thalassaemia in the southern China population for the first time. In addition, two novel mutations that give rise to alpha thalassaemia, one deletion resulting in beta thalassaemia, and a rare deletion (--(THAI) allele) previously unreported in mainland China were detected. The frequency of the most common mutation, the Southeast Asian type of deletion (--(SEA), accounting for 48.54% of all alpha thalassaemias) was similar to the total of two alpha(+) thalassaemia deletions (-alpha(3.7) and -alpha(4.2), accounting for 47.49% of alpha thalassaemia).
Conclusion: Both alpha and beta thalassaemia are widely distributed in Guangdong Province of China. The knowledge gained in this study will enable the projected number of pregnancies at risk to be estimated and a screening strategy for control of thalassaemia to be designed in this area.
Figures
Similar articles
-
Prevalence and spectrum of thalassaemia in Changsha, Hunan province, China: discussion of an innovative screening strategy.J Genet. 2017 Jun;96(2):327-332. doi: 10.1007/s12041-017-0779-6. J Genet. 2017. PMID: 28674233
-
[A study on gene mutation spectrums of α- and β-thalassemias in populations of Yunnan Province and the prenatal gene diagnosis].Zhonghua Fu Chan Ke Za Zhi. 2012 Feb;47(2):85-9. Zhonghua Fu Chan Ke Za Zhi. 2012. PMID: 22455737 Chinese.
-
[Large-scale population-based genetic screening and prenatal diagnosis for thalassemias in Zhuhai City of Guangdong Province].Zhonghua Fu Chan Ke Za Zhi. 2012 Feb;47(2):90-5. Zhonghua Fu Chan Ke Za Zhi. 2012. PMID: 22455738 Chinese.
-
Molecular study and prenatal diagnosis of alpha- and beta-thalassemias in Chinese.J Formos Med Assoc. 1998 Jan;97(1):5-15. J Formos Med Assoc. 1998. PMID: 9481058 Review.
-
Molecular Epidemiology and Hematologic Characterization of Thalassemia in Guangdong Province, Southern China.Clin Appl Thromb Hemost. 2022 Jan-Dec;28:10760296221119807. doi: 10.1177/10760296221119807. Clin Appl Thromb Hemost. 2022. PMID: 35979587 Free PMC article. Review.
Cited by
-
Up-regulation of NKG2A inhibitory receptor on circulating NK cells contributes to transfusion-induced immunodepression in patients with β-thalassemia major.J Huazhong Univ Sci Technolog Med Sci. 2016 Aug;36(4):509-513. doi: 10.1007/s11596-016-1616-5. Epub 2016 Jul 28. J Huazhong Univ Sci Technolog Med Sci. 2016. PMID: 27465324
-
The gene spectrum of thalassemia in Yangjiang of western Guangdong Province.Front Genet. 2023 Feb 13;14:1126099. doi: 10.3389/fgene.2023.1126099. eCollection 2023. Front Genet. 2023. PMID: 36861132 Free PMC article.
-
Carrier screening for beta-thalassaemia: a review of international practice.Eur J Hum Genet. 2010 Oct;18(10):1077-83. doi: 10.1038/ejhg.2010.90. Epub 2010 Jun 23. Eur J Hum Genet. 2010. PMID: 20571509 Free PMC article. Review.
-
Using affected embryos to establish linkage phase in preimplantation genetic testing for thalassemia.Reprod Biol Endocrinol. 2022 Apr 30;20(1):75. doi: 10.1186/s12958-022-00948-9. Reprod Biol Endocrinol. 2022. PMID: 35490243 Free PMC article.
-
Evaluation of intervention strategy of thalassemia for couples of childbearing ages in Centre of Southern China.J Clin Lab Anal. 2021 Oct;35(10):e23990. doi: 10.1002/jcla.23990. Epub 2021 Sep 7. J Clin Lab Anal. 2021. PMID: 34492731 Free PMC article.
References
-
- Weatherall DJ. Phenotype–genotype relationships in monogenic disease: lessons from the thalassaemias. Nat Rev Genet 2001;2:245–55. - PubMed
-
- Forget BG. Thalassemia syndromes. In: Hoffman R, Benz EJ Jr, Shattil SJ, et al, eds. Hematology: basic principles and practice. 3rd ed. Singapore: Harcourt Asia PTE, 2000:485–510.
-
- Chui DH, Fucharoen S, Chan V. Hemoglobin H disease: not necessarily a benign disorder. Blood 2003;101:791–800. - PubMed
-
- Cao A, Rosatelli MC, Monni G, et al. Screening for thalassemia: a model of success. Obstet Gynecol Clin North Am 2002;29:305–28, vi-vii. - PubMed
-
- Weatherall DJ, Clegg JB. Thalassemia—a global public health problem. Nat Med 1996;2:847–9. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources